1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 22 -28, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 22 -28, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 02/23/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Bill Cassidy (R-LA)

Event Date: 02/23/2026
Location: Washington, DC
Subject: National Association of Benefits and Insurance Professionals (NABIP) 36th Annual Capitol Conference
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry

Event Date: 02/24/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative John Joyce (R-PA)

Event Date: 02/24/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Rick Scott (R-FL)

Event Date: 02/24/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator John Boozman (R-AR), Representative Bruce Westerman (R-AR), Senator Tom Cotton, (R-AR)

Event Date: 02/24/2026
Location: Silver Spring, MD
Subject: Collaboration Opportunities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Barbara Schillo, Kathy Crosby, Robert Falk, Stacy Younger Gagosian (Truth Initiative);

Event Date: 02/24/2026
Location: Washington, DC
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Brett Guthrie (R-KY), Morgan Griffith (R-VA)

Event Date: 02/25/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Representative Buddy Carter (R-GA)

Event Date: 02/26/2026
Location: Silver Spring, MD
Subject: Premarket Tobacco Product Application (PMTA) Reviews and Collaborative Opportunities
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Swisher International, Inc. representatives

Event Date: 02/27/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Ron Johnson (R-WI)

Event Date: 02/27/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senator Tim Scott (R-SC)

Event Date: 02/27/2026
Location: Silver Spring, MD
Subject: Antibiotics in Food-Animal Production
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Liam Sacino (U.S. Public Interest Research Group (US-PIRG) Education Fund); Harry Rhodes, Steven Roach (Food Animal Concerns Trust (FACT));

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 02/24/2026
Location: Virtual
Subject: Implementation of United States-Abraham Accords Cooperation and Security Act
FDA Participant/Group: RAVI BHARWANI; MARK ABDOO; 
Non FDA Participant/Group: Cathy McMorris Rodgers, Heather Johnston, Joan Leslie McGill (U.S. Isreal Education Association); Peter Pitts (Center for Medicine in the Public Interest (CMPI)); E.J. Kimball (EJK Strategies);

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 02/23/2026
Location: Washington, DC
Subject: Food Safety Issues of Mutual Interest 
FDA Participant/Group: DONALD PRATER; TIMOTHY MUELLER; LAURIE FARMER; 
Non FDA Participant/Group: David Dyjack, Doug Farquhar, Rance Baker (National Environmental Health Association);

Event Date: 02/24/2026
Location: Washington, DC
Subject: Human Foods Program Budget Issues of Mutual Interest 
FDA Participant/Group: JESSICA DILLON; DANIEL HATTIS; DONALD PRATER; EMILY ROSE CAREY; 
Non FDA Participant/Group: Several members and staff of the House of Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies

Event Date: 02/26/2026
Location: Washington, DC
Subject: Food Nutrition and Ingredient Issues of Mutual Interest 
FDA Participant/Group: DONALD PRATER; 
Non FDA Participant/Group: Carli Liguori, Dianne Nellor, Matt Graziose, Max Finberg, Nishant Roy, Toure Burgess (Chobani);

Event Date: 02/26/2026
Location: Washington, DC
Subject: Introductory Meeting
FDA Participant/Group: ERIK METTLER; DONALD PRATER; 
Non FDA Participant/Group: National Association of County and City Health Officials Board of Directors

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

Event Date: 02/24/2026
Location: Silver Spring, MD
Subject: Issues of Mutual Interest
FDA Participant/Group: SAUMYENDU GHOSH; 
Non FDA Participant/Group: Brenda Smith (Expeditors International);

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 02/23/2026
Location: Washington, DC
Subject: Heart and Valve Collaboratory Leadership Summit; Speaker: Fireside Chat 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Event Date: 02/24/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Global Medical Device Nomenclature representatives

Event Date: 02/24/2026
Location: Virtual
Subject: Medical Device Manufacturing Excellence Summit; Speaker: FDA Regulatory Landscape: Driving Innovation, Quality, and Resilience in Medical Devices
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top